Cookies on the
LGC website
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we’ll assume that you are happy to receive all cookies on the LGC website. However, if you would like to, you can change your cookie settings at anytime.
Question markFind out more

05 Dec LGC and Desktop Genetics receive SynbiCITE funding to develop novel methods for CRISPR genome editing analysis

Funding helps develop screening and validation tools for functional genomics, cell line engineering and synthetic biology

11 Nov LGC appoints Brian Kim Managing Director, Genomics

LGC announced that it has appointed Brian Kim as Managing Director, Genomics, leading the group’s international Genomics division.

06 Apr LGC acquires Douglas Scientific to expand its high-throughput PCR platform offering

LGC announces that it has acquired a majority stake in Douglas Scientific

11 Jan KeyGene licenses Sequence-Based Genotyping technology to LGC

LGC obtains license for the commercial offering and use of KeyGene's patented SBG technology across all species

28 Oct Introducing the FlexSTAR+

Novel precipitation-chemistry system fully automates whole blood genomic DNA isolation from primary tubes to final DNA storage tubes